S9: #081: Scaling Digital Therapeutics - The Opportunities and Challenges

02/28/19 • 33 min

1 Listener

Digital Health Today 360 with Dan Kendall

In this episode, we’re taking on the topic of Digital Therapeutics. At the CNS Summit last year, I had the opportunity to meet our guest: Megan Coder. Megan is the founder and executive director of the Digital Therapeutics Alliance. The Digital Therapeutics Alliance, or DTA as you may hear it called, was launched in 2017 to broaden the understanding, adoption, and integration of clinically-validated digital therapeutic solutions into mainstream healthcare through education, advocacy, and research.

Megan has more than a decade of experience in the healthcare industry. She’s held roles that span from direct delivery of patient care, to leading the strategic growth within the digital health sector. Prior to DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association, and the Pharmacy Technician Certification Board. She’s a qualified pharmacist and a proud graduate from the University of Wisconsin like our guest in episode 63, Dale Beerman.

Enjoy this update on digital therapeutics and be sure to download the industry report below!

Today's Topics:

The ‘official' definition of ‘Digital Therapeutics'
The history and evolution of Digital Therapeutics
The similarities and differences of Digital Therapeutics and traditional Prescription Therapeutics
The current state of regulatory pathways available for Digital Therapeutics
How the FDA and other regulatory bodies assess the viability of Digital Therapeutics
The response to Digital Therapeutics by the traditional pharmaceutical industry
The founding members of the Digital Therapeutics Alliance and their mission and goals
The key stakeholders that are driving access and adoption of Digital Therapeutics

Links and Resources Mentioned:

Megan Coder on Twitter
Megan Coder on LinkedIn
Digital Therapeutics Alliance on Twitter
Digital Therapeutics Alliance on LinkedIn
Digital Therapeutics Alliance on the Web
Digital Therapeutics Industry Report – pdf
Digital Health Events
Join Digital Health Today

This episode of Digital Health Today is made possible thanks to our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

Enjoy this update on digital therapeutics and be sure to download the industry report below!

Today's Topics:

The ‘official' definition of ‘Digital Therapeutics'
The history and evolution of Digital Therapeutics
The similarities and differences of Digital Therapeutics and traditional Prescription Therapeutics
The current state of regulatory pathways available for Digital Therapeutics
How the FDA and other regulatory bodies assess the viability of Digital Therapeutics
The response to Digital Therapeutics by the traditional pharmaceutical industry
The founding members of the Digital Therapeutics Alliance and their mission and goals
The key stakeholders that are driving access and adoption of Digital Therapeutics

Links and Resources Mentioned:

Megan Coder on Twitter
Megan Coder on LinkedIn
Digital Therapeutics Alliance on Twitter
Digital Therapeutics Alliance on LinkedIn
Digital Therapeutics Alliance on the Web
Digital Therapeutics Industry Report – pdf
Digital Health Events
Join Digital Health Today

This episode of Digital Health Today is made possible thanks to our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

Previous Episode

S9: #080: The Human Microbiome, Algorithms and Home Test Kits

Lihi Segal on applying technology and predictive models to manage glucose levels

In this episode, we’re diving into the research, and a brand new solution, focused on the growing understanding of the human microbiome – the microorganisms that help protect us against germs, break down food, and produce vitamins.

What work is being done to actually enlist the microbiome in the fight against disease? Can we leverage our understanding not just to preserve health but also to actually prevent or treat metabolic disease? Here on Digital Health today, it is our job and privilege to find the leaders who are breaking new ground, and I’m pleased to introduce you to one of those leaders on this podcast.

With me on this episode is Lihi Segal, the CEO and Co-Founder of DayTwo. Lihi cofounded Day Two in 2015 to bring personalized health solutions based on the gut microbiome into the consumer mainstream. Before starting DayTwo, Lihi led business and financial operations as the COO and CFO of Sisense, which is a provider of business intelligence and analytics software. She’s also a qualified lawyer, and has an LLB from the Tel-Aviv University and an MBA from Northwestern University in the US.

For another episode about the human microbiome, tune into episode 48 where we spoke with Dr. Azza Gadir from Harvard about the relationship between the microbiome and the development and management of food allergies.

Videos:

What is the best diet for humans? | Eran Segal | TEDxRuppin

Personalized Nutrition/ Cell November 19, 2015 (Vol. 163, Issue 5)

This episode of Digital Health Today is made possible thanks to our sponsors. Thank you.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Next Episode

S9: #082: Dr. Thomas Insel on Digital Phenotyping as a Tool for Solving Mental Health

Today we’re diving into the topic of Mental Health. It’s a topic we’ve covered before on this program, like in episode 63 with Dale Beerman of Think Pacifica, and in episode 21 with Dr. Arshya Vahabzadeh from Brain Power. In those episodes, we explored the use of mobile apps and wearables, and we looked at some problems that are being solved using these technologies.

We often think of mental health as something that is just that – “mental” health – and the connections to physical health, and even the numbers of people who die due to poor mental health, are often under appreciated. We also know that if we increase activity and physical exercise it can help relieve symptoms of stress and improve aspects of our mental health. Wouldn’t it be great if there were tools available that could help measure and quantify our mental health based on our physical activities and behaviors? Maybe even serve as an early warning system?

Well, that’s why I wanted to introduce you to our next guest. His company is doing pioneering work in measurement science to provide continuous, objective measures of cognition and mood that can potentially alert patients and providers to early signs of mental health deterioration.

My guest is Dr. Thomas R. Insel, he is the Co-Founder & President of Mindstrong Health based in California. He is a psychiatrist and neuroscientist, and previously he was a Director of the National Institute of Mental Health, a Professor of Psychiatry at Emory University, and a leader of Verily’s Mental Health Team. Tom’s here to tell us about the research and work they’re doing at Mindstrong Health to use information from cell phones to drive better, earlier and deeper understandings about mental health.

I was introduced to Tom my Marco Mohwinckel and George Goldsmith over at Compass Pathways, a UK-based company working to develop treatments to empower patients suffering with mental illness. They are doing that by combining neuroscience, psychotherapy, psychopharmacology, and digital platforms. Thanks Marco and George for the introduction to Tom.

Today's Topics:

The relationship between Physical Health and Mental Health
Where does Mental Health space sit in the Healthcare Ecosystem
Dr. Insel's work in Mindstrong and an introduction to Digital Phenotyping
How does Digital Phenotyping work and how will it assist in understanding and solving mental health issues
The current business model of Mindstrong Health, where they are now, and how can consumers and organizations interact with their projects
Where will Mental Health be years from now in relation to the developments of this new technological intervention

Links and Resources Mentioned: